Anti-snoring Treatment Market (By Device: Mandible Advancement Devices, Tongue Stabilizing Devices, Nasal Devices, Continuous Positive Airway Pressure Devices, Chin Straps, Others; By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, E-commerce, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Anti-snoring Treatment Market 

5.1. COVID-19 Landscape: Anti-snoring Treatment Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Anti-snoring Treatment Market, By Device

8.1. Anti-snoring Treatment Market, by Device, 2024-2033

8.1.1. Mandible Advancement Devices

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Tongue Stabilizing Devices

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Nasal Devices

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Continuous Positive Airway Pressure Devices

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Chin Straps

8.1.5.1. Market Revenue and Forecast (2021-2033)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Anti-snoring Treatment Market, By Distribution Channel

9.1. Anti-snoring Treatment Market, by Distribution Channel, 2024-2033

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Clinics

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Retail Pharmacies

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. E-commerce

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Anti-snoring Treatment Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Device (2021-2033)

10.1.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Device (2021-2033)

10.1.3.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Device (2021-2033)

10.1.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Device (2021-2033)

10.2.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Device (2021-2033)

10.2.3.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Device (2021-2033)

10.2.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Device (2021-2033)

10.2.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Device (2021-2033)

10.2.6.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Device (2021-2033)

10.3.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Device (2021-2033)

10.3.3.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Device (2021-2033)

10.3.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Device (2021-2033)

10.3.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Device (2021-2033)

10.3.6.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Device (2021-2033)

10.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Device (2021-2033)

10.4.3.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Device (2021-2033)

10.4.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Device (2021-2033)

10.4.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Device (2021-2033)

10.4.6.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Device (2021-2033)

10.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Device (2021-2033)

10.5.3.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Device (2021-2033)

10.5.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)

Chapter 11. Company Profiles

11.1. Apnea Sciences Corp.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. SomnoMed Ltd.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Airway Management, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. ResMed Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Fisher & Paykel Healthcare Corp. Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Koninklijke Philips NV

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Sleep Well Enjoy Life, Ltd.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Tomed Dr. Toussaint GmbH

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. MEDiTAS Ltd.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample